Company Monitoring Page for MannKind

latest headlines for company on cafepharma

MannKind Is 'Making Progress' On Its Alternative To Mylan's EpiPen, Report Says
Yahoo/Benzinga
Wed, 08/31/16 - 09:15 am
Tags:
MannKind, Mylan Labs, EpiPen
MannKind turns to digital, social media to spread the word on Afrezza's relaunch
Fierce Pharma
Mon, 08/15/16 - 09:44 pm
Tags:
MannKind, Afrezza, diabetes, social media, drug launches
MannKind maps out Afrezza strategy
BioPharma Dive
Wed, 08/10/16 - 06:25 pm
Tags:
MannKind, Afrezza, diabetes, inhaled insulin
MannKind - Afrezza Scripts Lose Some Traction; Investors Need To Think About Realistic Impacts
Seeking Alpha
Tue, 08/9/16 - 11:29 am
Tags:
MannKind, Afrezza, diabetes, inhaled insulin
Mannkind Assumes Responsibility for Distribution of Afrezza® and Launches Patient Reimbursement and Adherence Support Programs
Yahoo
Tue, 08/2/16 - 08:45 am
Tags:
MannKind, Afrezza, diabetes, inhaled insulin
MannKind - Afrezza Scripts Starting Off Modestly On Relaunch
Seeking Alpha
Sat, 07/16/16 - 12:45 pm
Tags:
MannKind, Afrezza, inhaled insulin, diabetes
MannKind 2.0 Launch: No Room For Error
Seeking Alpha
Fri, 07/1/16 - 09:36 am
Tags:
MannKind, Afrezza, drug launches, inhaled insulin, diabetes
Inhaled insulin company Mannkind hiring med tech sales reps to recover from failed marketing partnership with Sanofi
Mass Device
Tue, 06/28/16 - 11:22 am
Tags:
MannKind, hirings, Afrezza, diabetes, inhaled insulin, Sanofi, devices, device reps
MannKind - Afrezza Scripts Still Slipping Ahead Of Re-Launch
Seeking Alpha
Sat, 06/25/16 - 01:37 pm
Tags:
MannKind, Sanofi, Afrezza, diabetes, inhaled insulin
MannKind Will Market Afrezza Better Than Sanofi Ever Did
Forbes
Fri, 06/24/16 - 04:07 pm
Tags:
MannKind, Afrezza, Sanofi, inhaled insulin, diabetes
Mannkind Afrezza Launch 2.0: How It Is Different This Time Around
Seeking Alpha
Mon, 06/20/16 - 09:48 pm
Tags:
MannKind, Afrezza, diabetes, inhaled insulin, drug launches
MannKind - Managing Expectations Of An Afrezza Relaunch
Seeking Alpha
Fri, 06/17/16 - 09:36 pm
Tags:
MannKind, Afrezza, diabetes, inhaled insulin
MannKind Announces Late-Breaking Data Reinforcing Faster Onset and Shorter Duration of Action Compared to Mealtime Insulins
Yahoo
Sun, 06/12/16 - 09:59 pm
Tags:
MannKind, Afrezza, diabetes, inhaled insulin
Top Equity Manager Still Believes In MannKind
Forbes
Wed, 06/1/16 - 10:11 am
Tags:
MannKind, Afrezza, inhaled insulin, diabetes
Here's Why MannKind Corporation is Down Big Today
Motley Fool
Tue, 05/10/16 - 05:08 pm
Tags:
earnings, MannKind
MannKind and Its CEO Fail Simple Financial Literacy Test
TheStreet.com
Wed, 04/27/16 - 09:18 am
Tags:
MannKind, Sanofi, Afrezza, Matt Pfeffer
MannKind: It's Not Bankruptcy, But...
Seeking Alpha
Tue, 04/19/16 - 09:37 am
Tags:
MannKind, bankruptcy
MannKind's Road To Riches - Sales, Sales And More Sales
Seeking Alpha
Tue, 04/12/16 - 07:47 am
Tags:
MannKind, Afrezza, Sanofi, inhaled insulin, diabetes
Back in control of Afrezza, MannKind refocuses on endocrinologists to give launch a jolt
Fierce Pharma Marketing
Mon, 04/11/16 - 11:19 pm
Tags:
MannKind, Afrezza, diabetes, Sanofi, inhaled insulin
MannKind to Discuss U.S. Commercialization Update for Afrezza
Yahoo
Mon, 04/11/16 - 09:56 am
Tags:
MannKind, Afrezza, inhaled insulin, diabetes

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.